Apidos CLO (APID) XL

ClassCCYSZE(M)WALMOSPFIDRKRC/ELTVTYPEBNCHGDNCSPRDCPNYLDPRICE
A-1USD320.000-Aaa----36.00%-FloatingSOFR-180SOFR+180-100.00000
A-2USD10.000-Aaa----34.00%-FloatingSOFR-200SOFR+200-100.00000
BUSD46.500---AA--24.70%-FloatingSOFR230-240250SOFR+250-100.00000
CUSD28.000---A--19.10%-FloatingSOFR-325SOFR+325-100.00000
DUSD33.000---BBB---12.50%-FloatingSOFR400-425430SOFR+430-100.00000
EUSD18.000---BB---8.90%-FloatingSOFR800785SOFR+769-99.00000
FUSD1.000-B3----8.70%-FloatingSOFR900-925900SOFR+850-97.00000
SubUSD42.900---------------
Tranche Comments
A-1: First Pay: 2023-01-15; Redemption: 2024-07-15; Registration: 144A/Reg S; A-2: First Pay: 2023-01-15; Redemption: 2024-07-15; Registration: 144A/Reg S; B: First Pay: 2023-01-15; Redemption: 2024-07-15; Registration: 144A/Reg S; C: First Pay: 2023-01-15; Redemption: 2024-07-15; Registration: 144A/Reg S; D: First Pay: 2023-01-15; Redemption: 2024-07-15; Registration: 144A/Reg S; E: First Pay: 2023-01-15; Redemption: 2024-07-15; Registration: 144A/Reg S; F: First Pay: 2023-01-15; Redemption: 2024-07-15; Registration: 144A/Reg S; Sub: First Pay: 2023-01-15; Redemption: 2024-07-15; Registration: 144A/Reg S;
Deal Comments
Non Call Period: 2.00
Risk Retention
EU - Yes
Reinvestment Period (YRS)
5
Reinvestment Period End Date
Jul 15, 2027
WAL Test Period (YRS)
9
WAL Test Period End Date
Jul 15, 2031
Research
AllReportsSurveillanceOther

Explore all other research.